Skip to main content

Advertisement

Log in

Cardiovascular Benefits of Black Cumin (Nigella sativa)

  • Published:
Cardiovascular Toxicology Aims and scope Submit manuscript

Abstract

Black Cumin (Nigella sativa), which belongs to the botanical family of Ranunculaceae, commonly grows in Eastern Europe, the Middle East, and Western Asia. Its ripe fruit contains tiny black seeds, known as “Al-Habba Al-Sauda” and “Al-Habba Al-Barakah” in Arabic and black seed or black cumin in English. Seeds of Nigella sativa are frequently used in folk medicine in the Middle East and some Asian countries for the promotion of good health and the treatment of many ailments. However, data for the cardiovascular benefits of black cumin are not well-established. We reviewed the literature from 1960 to March 2012 by using the following key words: “Nigella sativa,” “black seeds,” and “thymoquinone.” Herein, we discussed the most relevant articles to find out the role of Nigella sativa in the cardiovascular diseases spectrum especially when there is a paucity of information and need of further studies in human to establish the utility of Nigella sativa in cardiovascular system protection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Cooper, E. L. (2004). Complementary and alternative medicine, when rigorous, can be science. Evidence-Based Complementary and Alternative Medicine, 1, 1–4.

    Article  PubMed  Google Scholar 

  2. Zohary, D., & Hopf, M. (2001). Domestication of plants in the old world. Oxford: Oxford University Press.

    Google Scholar 

  3. Ghosheh, A. O., Houdi, A. A., & Crooks, A. P. (1998). High performance liquid chromatographic analysis of the pharmacologically active quinines and related compounds in the oil of the black seed [N. sativa L.]. Journal of Pharmaceutical and Biomedical Analysis, 19, 757–762.

    Article  Google Scholar 

  4. Padhye, S., Banerjee, S., Ahmad, A., et al. (2008). From here to eternity—The secret of Pharaohs: Therapeutic potential of black cumin seeds and beyond. Cancer Therapy, 6(b), 495–510.

    PubMed  CAS  Google Scholar 

  5. Al-Bukhari, M. I. (1976). Division [71] on medicine. In Sahih. Al-Bukhari (Ed.), The collection of authentic sayings of Prophet Mohammad [peace be upon him] (2nd ed.). Ankara, Turkey: Hilal Yayinlari.

    Google Scholar 

  6. Bakathir, H., & Abbas, N. (2011). Detection of the antibacterial effect of Nigella sativa ground seeds with water. African Journal of Traditional, Complementary and Alternative Medicines, 8(2), 159–164.

    Article  Google Scholar 

  7. Mannan, A., & Kahvic, M. (2010). Ibn Sina: A tribute. The Gulf Journal of Oncology, 7, 60–63.

    PubMed  Google Scholar 

  8. Aggarwal, B. B., Kunnumakkara, A. B., Harikumar, K. B., et al. (2008). Potential of spice-derived phytochemicals for cancer prevention. Planta Medica, 74(13), 1560–1569.

    Article  PubMed  CAS  Google Scholar 

  9. Randhawa, M., & Alghamdi, M. (2011). Anticancer activity of Nigella sativa [black seed]—A review. American Journal of Chinese Medicine, 39(6), 1075–1091.

    Article  PubMed  CAS  Google Scholar 

  10. Aqel, M., & Shaheen, R. (1996). Effects of the volatile oil of Nigella sativa seeds on the uterine smooth muscle of rat and guinea pig. Journal of Ethnopharmacology, 52, 23–26.

    Article  PubMed  CAS  Google Scholar 

  11. Chakravorty, N. (1993). Inhibition of histamine release from mast cells by Nigellone. Annals of Allergy, 70, 237–242.

    Google Scholar 

  12. Zaoui, A., Cherrah, Y., Lacaille-Dubois, M. A., et al. (2000). Diuretic and hypotensive effects of Nigella sativa in the spontaneously hypertensive rat. Therapie, 55, 379–382.

    PubMed  CAS  Google Scholar 

  13. Al-Hader, A., Aqel, A., & Hassan, Z. (1993). Hypoglycemic effects of the volatile oil of Nigella sativa seeds. International Journal of Pharmacology, 31, 96–100.

    Article  Google Scholar 

  14. Khan, M. A., Ashfaq, M. K., Zuberi, H. S., et al. (2003). The in vivo antifungal activity of the aqueous extract from Nigella sativa seeds. Phytotherapy Research, 17, 183–186.

    Article  PubMed  CAS  Google Scholar 

  15. Al-Ghamdi, M. S. (2001). The anti-inflammatory, analgesic and antipyretic activity of Nigella sativa. Journal of Ethnopharmacology, 76, 45–48.

    Article  PubMed  CAS  Google Scholar 

  16. Worthen, D. R., Ghosheh, O. A., & Crooks, P. A. (1998). The in vitro anti-tumor activity of some crude and purified components of blackseed, Nigella sativa L. Anticancer Research, 18, 1527–1532.

    PubMed  CAS  Google Scholar 

  17. Ali, B., & Blunden, G. (2003). Pharmacological and toxicological properties of Nigella sativa. Phytotherapy Research, 17(4), 299–305.

    Article  PubMed  CAS  Google Scholar 

  18. Nickavar, B., Mojab, F., Javidnia, K., & Amoli, M. (2003). Chemical composition of the fixed and volatile oils of Nigella sativa L. from Iran. Zeitschrift für Naturforschung C, 58(9–10), 629–631.

    CAS  Google Scholar 

  19. Houghton, P., Zarka, R., de las Heras, B., & Hoult, J. R. (1995). Fixed oil of Nigella sativa and derived thymoquinone inhibit eicosanoid generation in leukocytes and membrane lipid peroxidation. Planta Medica, 61(1), 33–36.

    Article  PubMed  CAS  Google Scholar 

  20. Abou-Basha, L., Rashed, M. S., & Aboul-Enein, H. Y. (1995). Thin layer chromatographic assay of thymoquinone in black seed oil and identification of dithymoquinone and thymol. Journal of Liquid Chromatography, 18, 105–115.

    Article  CAS  Google Scholar 

  21. Al-Ali, A., Alkhawajah, A. A., Randhawa, M. A., & Shaikh, N. A. (2008). Oral and intraperitoneal LD50 of thymoquinone, an active principle of Nigella sativa, in mice and rats. Journal of Ayub Medical College, Abbottabad, 20(2), 25–27.

    PubMed  Google Scholar 

  22. Kaleem, M., Kirmani, D., Asif, M., et al. (2006). Biochemical effects of Nigella sativa L. seeds in diabetic rats. Indian Journal of Experimental Biology, 44(9), 745–748.

    PubMed  CAS  Google Scholar 

  23. Bamosa, A., Kaatabi, H., Lebdaa, F., et al. (2010). Effect of Nigella sativa seeds on the glycemic control of patients with type 2 diabetes mellitus. Indian Journal of Physiology and Pharmacology, 54(4), 344–354.

    PubMed  Google Scholar 

  24. Benhaddou-Andaloussi, A., Martineau, L., Vuong, T., et al. (2011). The in vivo antidiabetic activity of Nigella sativa is mediated through activation of the AMPK pathway and increased muscle Glut4 content. Evidence-Based Complementary and Alternative Medicine. Article ID: 538671. [Epub 2011 April 14].

  25. Kanter, M., Akpolat, M., & Aktas, C. (2009). Protective effects of the volatile oil of Nigella sativa seeds on beta-cell damage in streptozotocin-induced diabetic rats: A light and electron microscopic study. Journal of Molecular Histology, 40(5–6), 379–385.

    Article  PubMed  CAS  Google Scholar 

  26. Demir, H., Kanter, M., Coskun, O., et al. (2006). Effect of black cumin [Nigella sativa] on heart rate, some hematological values, and pancreatic beta-cell damage in cadmium-treated rats. Biological Trace Element Research, 110(2), 151–162.

    Article  PubMed  CAS  Google Scholar 

  27. Abdelmeguid, N., Fakhoury, R., Kamal, S., & Al Wafai, R. (2010). Effects of Nigella sativa and thymoquinone on biochemical and subcellular changes in pancreatic β-cells of streptozotocin-induced diabetic rats. Journal of Diabetes, 2(4), 256–266.

    Article  PubMed  CAS  Google Scholar 

  28. Kanter, M., Meral, I., Yener, Z., et al. (2003). Partial regeneration/proliferation of the beta-cells in the islets of Langerhans by Nigella sativa L. in streptozotocin-induced diabetic rats. Tohoku Journal of Experimental Medicine, 201(4), 213–219.

    Article  PubMed  Google Scholar 

  29. El-Dakhakhny, M., Mady, N., Lembert, N., & Ammon, H. (2002). The hypoglycemic effect of Nigella sativa oil is mediated by extrapancreatic actions. Planta Medica, 68(5), 465–466.

    Article  PubMed  CAS  Google Scholar 

  30. Fararh, K., Atoji, Y., Shimizu, Y., et al. (2004). Mechanisms of the hypoglycaemic and immunopotentiating effects of Nigella sativa L. oil in streptozotocin-induced diabetic hamsters. Research in Veterinary Science, 77(2), 123–129.

    Article  PubMed  CAS  Google Scholar 

  31. Kanter, M. (2008). Effects of Nigella sativa and its major constituent, thymoquinone on sciatic nerves in experimental diabetic neuropathy. Neurochemical Research, 33(1), 87–96.

    Article  PubMed  CAS  Google Scholar 

  32. Hamdy, N., & Taha, R. (2009). Effects of Nigella sativa oil and thymoquinone on oxidative stress and neuropathy in streptozotocin-induced diabetic rats. Pharmacology, 84(3), 127–134.

    Article  PubMed  CAS  Google Scholar 

  33. Meddah, B., Ducroc, R., El Abbes Faouzi, M., et al. (2009). Nigella sativa inhibits intestinal glucose absorption and improves glucose tolerance in rats. Journal of Ethnopharmacology, 121(3), 419–424.

    Article  PubMed  Google Scholar 

  34. Rchid, H., Chevassus, H., Nmila, R., et al. (2004). Nigella sativa seed extracts enhance glucose-induced insulin release from rat-isolated Langerhans islets. Fundamental & Clinical Pharmacology, 18(5), 525–529.

    Article  CAS  Google Scholar 

  35. Le, P., Benhaddou-Andaloussi, A., Elimadi, A., et al. (2004). The petroleum ether extract of Nigella sativa exerts lipid-lowering and insulin-sensitizing actions in the rat. Journal of Ethnopharmacology, 94(2–3), 251–259.

    Article  PubMed  Google Scholar 

  36. Benhaddou-Andaloussi, A., Martineau, L., Vallerand, D., et al. (2010). Multiple molecular targets underlie the antidiabetic effect of Nigella sativa seed extract in skeletal muscle, adipocyte and liver cells. Diabetes, Obesity & Metabolism, 12(2), 148–157.

    Article  CAS  Google Scholar 

  37. Najmi, A., Nasiruddin, M., Khan, R. A., & Haque, S. F. (2008). Effect of Nigella sativa oil on various clinical and biochemical parameters of insulin resistance syndrome. International Journal of Diabetes in Developing Countries, 28(1), 11–14.

    Article  PubMed  Google Scholar 

  38. Qidwai, W., Hamza, H., & Gilani, A. (2009). Effectiveness, safety and tolerability of powdered Nigella sativa [kalonji] seed in capsules on serum lipid levels, blood sugar, blood pressure and body weight in adults: Results of a randomized, double blind controlled trial. Journal of Alternative and Complementary Medicine, 15, 639–644.

    Article  Google Scholar 

  39. Nader, M., El-Agamy, D., & Suddek, G. (2010). Protective effects of propolis and thymoquinone on development of atherosclerosis in cholesterol-fed rabbits. Archives of Pharmacal Research, 33(4), 637–643.

    Article  PubMed  CAS  Google Scholar 

  40. Al-Naqeep, G., Al-Zubairi, A. S., Ismail, M., et al. (2011). Antiatherogenic potential of Nigella sativa seeds and oil in diet-induced hypercholesterolemia in rabbits. Evidence-Based Complementary and Alternative Medicine. doi:10.1093/ecam/neq071.

  41. El-Dakhakhny, M., Mady, N., & Halim, M. (2000). Nigella sativa L. oil protects against induced hepatotoxicity and improves serum lipid profile in rats. Arzneimittel-Forschung, 50(9), 832–836.

    PubMed  CAS  Google Scholar 

  42. Zaoui, Y., Cherrah, K., Alaoui, K., et al. (2002). Effects of Nigella sativa fixed oil on blood homeostasis in rat. Journal of Ethnopharmacology, 79(1), 23–26.

    Article  PubMed  CAS  Google Scholar 

  43. Bhatti, I. U., Ur Rehman, F., Khan, M. A., & Marwat, S. K. (2009). Effect of prophetic medicine kalonji [Nigella sativa l.] on lipid profile of human beings. An invivo approach. World Applied Sciences Journal, 6(8), 1053–1057.

    CAS  Google Scholar 

  44. Bamosa, A. O., Ali, B. A., & Sowayan, S. A. (1997). Effect of oral ingestion of Nigella sativa seeds on some blood parameters. Saudi Pharmaceutical Journal, 5, 126–129.

    Google Scholar 

  45. Tasawar, Z., Siraj, Z., Ahmad, N., & Lashari, M. H. (2011). The effects of Nigella sativa [Kalonji] on lipid profile in patients with stable coronary artery disease in Multan, Pakistan. Pakistan Journal of Nutrition, 10(2), 162–167.

    Article  CAS  Google Scholar 

  46. Dehkordi, F., & Kamkhah, A. (2008). Antihypertensive effect of Nigella sativa seed extract in patients with mild hypertension. Fundamental & Clinical Pharmacology, 22(4), 447–452.

    Article  CAS  Google Scholar 

  47. Bamosa, A. O., Ali, B. A., & Al-Hawsawi, Z. A. (2002). The effect of thymoquinone on blood lipids in rats. Indian Journal of Physiology and Pharmacology, 46, 195–201.

    PubMed  CAS  Google Scholar 

  48. Kanter, M., Coskun, O., & Budancamanak, M. (2005). Hepatoprotective effects of Nigella sativa L. and Urtica dioica L. on lipid peroxidation, antioxidant enzyme systems and liver enzymes in carbon tetrachloride-treated rats. World Journal of Gastroenterology, 11(42), 6684–6688.

    PubMed  Google Scholar 

  49. Mat, M. C., Mohamed, A. S., & Hamid, S. S. (2011). Primary human monocyte differentiation regulated by Nigella sativa pressed oil. Lipids in Health and Disease, 10, 216–226.

    Article  PubMed  CAS  Google Scholar 

  50. Krieger, M. (1997). The other site of scavenger receptors. Pattern recognition and host defense. Current Opinion in Lipidology, 8, 275–280.

    Article  PubMed  CAS  Google Scholar 

  51. Vanhoutte, P., Shimokawa, H., Tang, E. H., & Feletou, M. (2009). Endothelial dysfunction and vascular disease. Acta Physiology [Oxford], 196(2), 193–222.

    Article  CAS  Google Scholar 

  52. Idris-Khodja, N., & Schini-Kerth, V. (2012). Thymoquinone improves aging-related endothelial dysfunction in the rat mesenteric artery. Naunyn Schmiedebergs Arch Pharmacology [Epub ahead of print].

  53. Enomoto, S., Asano, R., Iwahori, Y., et al. (2001). Hematological studies on black cumin oil from the seeds of Nigella sativa L. Biological and Pharmaceutical Bulletin, 24(3), 307–310.

    Article  PubMed  CAS  Google Scholar 

  54. Mahfouz, M., & El-Dakhakhny, M. (1960). Chemical and pharmacological properties of the new antiasthmatic drug, nigellone. Egyptian Pharmacology Bulletin, 42, 411–424.

    CAS  Google Scholar 

  55. El-Tahir, K., Ashour, M., & Al-Harbi, M. (1993). The cardiovascular actions of the volatile oil of the black seed [Nigella sativa] in rats: Elucidation of the mechanism of action. General Pharmacology, 24, 1123–1131.

    Article  PubMed  CAS  Google Scholar 

  56. Khattab, M. M., & Nagi, M. N. (2007). Thymoquinone supplementation attenuates hypertension and renal damage in nitric oxide deficient hypertensive rats. Phytotherapy Research, 21, 410–414.

    Article  PubMed  CAS  Google Scholar 

  57. El-Bahai, M. N., Al-Hariri, M. T., Yar, T., & Bamosa, A. O. (2009). Cardiac inotropic and hypertrophic effects of Nigella sativa supplementation in rats. International Journal of Cardiology, 131(3), e115–e117.

    Article  PubMed  CAS  Google Scholar 

  58. Al-Hariri, M. T., Yar, T., Bamosa, A. O., & El-Bahai, M. N. (2009). Effects of two-month Nigella sativa supplementation on cardiac hemodynamics and adrenergic responsiveness. The Journal of Pakistan Medical Association, 59(6), 363–368.

    Google Scholar 

  59. Boskabady, M. H., Shafie, M. N., & Parsaee, H. (2005). Effect of aqueous and macerated extracts from Nigella sativa on guinea pig isolated heart activity. Pharmazie, 60(12), 943–948.

    PubMed  CAS  Google Scholar 

  60. Shafie, M. N., Boskabady, M. H., & Parsaee, H. (2005). Effect of aqueous extract from Nigella sativa L. on guinea pig isolated heart. Indian Journal of Experimental Biology, 43(7), 635–639.

    Google Scholar 

  61. Rezzani, R. (2006). Exploring cyclosporine A-side effects and the protective role-played by antioxidants: The morphological and immunohistochemical studies. Histology and Histopathology, 21, 301–316.

    PubMed  CAS  Google Scholar 

  62. Nishiyama, A., Kobori, H., Fukui, T., et al. (2003). Role of angiotensin II and reactive oxygen species in cyclosporine A-dependent hypertension. Hypertension, 42, 754–760.

    Article  PubMed  CAS  Google Scholar 

  63. Ebru, U., Burak, U., Yusuf, S., et al. (2008). Cardioprotective effects of Nigella sativa oil on cyclosporine A-induced cardiotoxicity in rats. Basic & Clinical Pharmacology & Toxicology, 103, 574–580.

    Article  CAS  Google Scholar 

  64. Nagi, M. N., Al-Shabanah, O., Hafez, M., & Sayed-Ahmed, M. (2011). Thymoquinone supplementation attenuates cyclophosphamide-induced cardiotoxicity in rats. Journal of Biochemical and Molecular Toxicology, 25(3), 135–142.

    Article  PubMed  CAS  Google Scholar 

  65. Al-Shabanah, O. A., Badary, O. A., Nagi, M. N., et al. (1998). Thymoquinone protects against doxorubicin-induced cardiotoxicity without compromising its antitumor activity. Journal of Experimental & Clinical Cancer Research, 17, 193–198.

    CAS  Google Scholar 

  66. Effenberger-Neidnicht, K., & Schobert, R. (2011). Combinatorial effects of thymoquinone on the anti-cancer activity of doxorubicin. Cancer Chemotherapy and Pharmacology, 67(4), 867–874.

    Article  PubMed  CAS  Google Scholar 

  67. Nagi, M. N., & Mansour, M. (2000). Protective effect of thymoquinone against doxorubicin-induced cardiotoxicity in rats: A possible mechanism of protection. Pharmacological Research, 41(3), 283–289.

    Article  PubMed  CAS  Google Scholar 

  68. El-Saleh, S. C., Al-Sagair, O. A., & Al-Khalaf, M. I. (2004). Thymoquinone and Nigella sativa oil protection against methionine-induced hyperhomocysteinemia in rats. International Journal of Cardiology, 93(1), 19–23.

    Article  PubMed  Google Scholar 

  69. Ali, B., Bamosa, A., & Al-Hawsawi, Z. (2003). Effect of Nigella sativa on blood lipids in normal rats. Arab Gulf Journal of Scientific Research, 21, 102–109.

    Google Scholar 

  70. Dahri, A. H., Chandiol, A. M., Rahoo, A. A., & Memon, R. A. (2005). Effect of Nigella sativa [kalonji] on serum cholesterol of albino rats. Journal of Ayub Medical College, Abbottabad, 17(2), 72–74.

    PubMed  Google Scholar 

  71. Yar, T., El-Hariri, M., El-Bahai, M., et al. (2008). Effects of Nigella sativa supplementation for one month on cardiac reserve in rats. Indian Journal of Physiology and Pharmacology, 52(2), 141–148.

    PubMed  CAS  Google Scholar 

  72. Ragheb, A., Elbarbry, F., Prasad, K., et al. (2008). Attenuation of the development of hypercholesterolemic atherosclerosis by thymoquinone. International Journal of Angiology, 17(4), 186–192.

    Article  PubMed  Google Scholar 

  73. Sultan, M., Butt, M., Ahmad, R., et al. (2012). Supplementation of Nigella sativa fixed and essential oil mediates potassium bromate induced oxidative stress and multiple organ toxicity. Pakistan Journal of Pharmaceutical Sciences, 25(1), 175–181.

    PubMed  CAS  Google Scholar 

  74. Woo, C., Kumar, A., Sethi, G., & Tan, K. (2012). Thymoquinone: Potential cure for inflammatory disorders and cancer. Biochemical Pharmacology, 83(4), 443–451.

    Article  PubMed  CAS  Google Scholar 

  75. Tripathi, Y., Chaturvedi, A., & Pandey, N. (2012). Effect of Nigella sativa seeds extracts on iNOS through antioxidant potential only: Crude/total extract as molecular therapy drug. Indian Journal of Experimental Biology, 50(6), 413–418.

    PubMed  Google Scholar 

  76. Badary, O. A., Abdel Naim, A. B., Abdel Wahab, M. H., & Hamada, F. M. (2000). Induced hyperlipedimic nephropathy in rats. Toxicology, 143(3), 219–226.

    Article  PubMed  CAS  Google Scholar 

  77. Sayed-Ahmed, M. M., & Nagi, M. N. (2007). Thymoquinone supplementation prevents the development of gentamicin-induced acute renal toxicity in rats. Clinical and Experimental Pharmacology and Physiology, 34, 399–405.

    Article  PubMed  CAS  Google Scholar 

  78. Kanter, M., Demir, H., Karakaya, C., & Ozbek, H. (2005). Gastroprotective activity of Nigella sativa L. oil and its constituent, thymoquinone against acute alcohol-induced gastric mucosal injury in rats. World Journal of Gastroenterology, 11, 6662–6666.

    PubMed  Google Scholar 

  79. Rastogi, L., Feroz, S., Pandey, B. N., et al. (2010). Protection against radiation-induced oxidative damage by an ethanolic extract of Nigella sativa L. International Journal of Radiation Biology, 86(9), 719–731.

    Article  PubMed  CAS  Google Scholar 

  80. Yildiz, F., Coban, S., Terzi, A., et al. (2008). Nigella sativa relieves the deleterious effects of ischemia reperfusion injury on liver. World Journal of Gastroenterology, 14(33), 5204–5209.

    Article  PubMed  Google Scholar 

  81. Coban, S., Yildiz, F., Terzi, A., et al. (2010). The effects of Nigella sativa on bile duct ligation induced-liver injury in rats. Cell Biochemistry and Function, 28(1), 83–88.

    Article  PubMed  CAS  Google Scholar 

  82. Daba, M. H., & Abdel-Rahman, M. S. (1998). Hepatoprotective activity of thymoquinone in isolated rat hepatocytes. Toxicology Letters, 95(1), 23–29.

    Article  PubMed  CAS  Google Scholar 

  83. Nagi, M. N., Alam, K., Badary, O. A., et al. (1999). Thymoquinone protects against carbon tetrachloride hepatotoxicity in mice via an antioxidant mechanism. Biochemistry and Molecular Biology International, 47(1), 153–159.

    PubMed  CAS  Google Scholar 

  84. Nili-Ahmadabadi, A., Tavakoli, F., Hasanzadeh, G., et al. (2011). Protective effect of pretreatment with thymoquinone against Aflatoxin B[1] induced liver toxicity in mice. Daru, 19(4), 282–287.

    PubMed  CAS  Google Scholar 

  85. Farrag, A., Mahdy, K., Abdel Rahman, G., & Osfor, M. (2007). Protective effect of Nigella sativa seeds against lead-induced hepatorenal damage in male rats. Pakistan Journal of Biological Sciences, 10(17), 2809–2816.

    Article  PubMed  CAS  Google Scholar 

  86. Michel, C., El-Sayed, N., Moustafa, S., et al. (2011). Phytochemical and biological investigation of the extracts of Nigella sativa L. seed waste. Drug Testing And Analysis, 3(4), 245–254.

    Article  PubMed  CAS  Google Scholar 

  87. Helal, G. (2010). Thymoquinone supplementation ameliorates acute endotoxemia-induced liver dysfunction in rats. Pakistan Journal of Pharmaceutical Sciences, 23(2), 131–137.

    PubMed  CAS  Google Scholar 

  88. Salem, M. L. (2005). Immunomodulatory and therapeutic properties of the Nigella sativa L. seed. International Immunopharmacology, 5, 1749–1770.

    Article  PubMed  CAS  Google Scholar 

  89. Boskabady, M. H., Javan, H., Sajady, M., & Rakhshandeh, H. (2007). The possible prophylactic effect of N. sativa seed extract in asthmatic patients. Fundamental & Clinical Pharmacology, 21(5), 559–566.

    Article  CAS  Google Scholar 

  90. Vaillancourt, F., Silva, P., Shi, Q., et al. (2011). Elucidation of molecular mechanisms underlying the protective effects of thymoquinone against rheumatoid arthritis. Journal of Cellular Biochemistry, 112(1), 107–117.

    Article  PubMed  CAS  Google Scholar 

  91. Gheita, T., & Kenawy, S. (2011). Effectiveness of Nigella sativa oil in the management of rheumatoid arthritis patients: A Placebo controlled study. Phytotherapy Research. doi:10.1002/ptr.36 [Epub ahead of print].

  92. Roepke, M., Diestel, A., Bajbouj, K., et al. (2007). Lack of p53 augments thymoquinone-induced apoptosis and caspase activation in human osteosarcoma cells. Cancer Biology & Therapy, 6(2), 160–169.

    Article  CAS  Google Scholar 

  93. Gali-Muhtasib, H., Roessner, A., & Schneider-Stock, R. (2006). Thymoquinone: A promising anti-cancer drug from natural sources. International Journal of Biochemistry & Cell Biology, 38(8), 1249–1253.

    Article  CAS  Google Scholar 

  94. Sethi, G., Ahn, K., & Aggarwal, B. (2008). Targeting nuclear factor-{kappa}B activation pathway by thymoquinone: Role in suppression of antiapoptotic gene products and enhancement of apoptosis. Molecular Cancer Research, 6, 1059–1070.

    Article  PubMed  CAS  Google Scholar 

  95. Yi, T., Cho, S., Yi, Z., et al. (2008). Thymoquinone inhibits tumor angiogenesis and tumor growth through suppressing AKT and extracellular signal-regulated kinase signaling pathways. Molecular Cancer Therapeutics, 7(7), 1789–1796.

    Article  PubMed  CAS  Google Scholar 

  96. Kaseb, A. O., Chinnakannu, K., Chen, D., et al. (2007). Androgen receptor and E2F-1 targeted thymoquinone therapy for hormone-refractory prostate cancer. Cancer Research, 67, 7782–7788.

    Article  PubMed  CAS  Google Scholar 

  97. Abusnina, A., Alhosin, M., Keravis, T., et al. (2011). Down-regulation of cyclic nucleotide phosphodiesterase PDE1A is the key event of p73 and UHRF1 deregulation in thymoquinone-induced acute lymphoblastic leukemia cell apoptosis. Cellular Signalling, 23(1), 152–160.

    Article  PubMed  CAS  Google Scholar 

  98. Hadjzadeh, M. A., Keshavarzi, Z., Tabatabaee-Yazdi, S., et al. (2012). Effect of alcoholic extract of Nigella sativa on cisplatin-induced toxicity in rat. Iranian Journal of Kidney Diseases, 6(2), 99–104.

    PubMed  Google Scholar 

  99. Badary, O. A., Nagi, M. N., Al-Shabanah, O. A., et al. (1997). Thymoquinone ameliorates the nephrotoxicity induced by cisplatin in rodents and potentiates its antitumor activity. Canadian Journal of Physiology and Pharmacology, 75(12), 1356–1361.

    Article  PubMed  CAS  Google Scholar 

  100. Badary, O. A. (1999). Thymoquinone attenuates ifosfamide-induced Fanconi syndrome in rats and enhances its antitumor activity in mice. Journal of Ethnopharmacology, 67(2), 135–142.

    Article  PubMed  CAS  Google Scholar 

  101. Banerjee, S., Kaseb, A., Wang, Z., et al. (2009). Antitumor activity of gemcitabine and oxaliplatin is augmented by thymoquinone in pancreatic cancer. Cancer Research, 69(13), 5575–5583.

    Article  PubMed  CAS  Google Scholar 

  102. Morsi, N. (2000). Antimicrobial effect of crude extracts of Nigella sativa on multiple antibiotics-resistant bacteria. Acta Microbiologica Polonica, 49(1), 63–74.

    PubMed  CAS  Google Scholar 

  103. Hanafy, M. S., & Hatem, M. E. (1991). Studies on the antimicrobial activity of Nigella sativa seed [black cumin]. Journal of Ethnopharmacology, 34(2–3), 275–278.

    Article  PubMed  CAS  Google Scholar 

  104. Kokoska, L., Havlik, J., Valterova, I., et al. (2008). Comparison of chemical composition and antibacterial activity of Nigella sativa seed essential oils obtained by different extraction methods. Journal of Food Protection, 71(12), 2475–2480.

    PubMed  CAS  Google Scholar 

  105. Hannan, A., Saleem, S., Chaudhary, S., et al. (2008). Anti bacterial activity of Nigella sativa against clinical isolates of methicillin resistant Staphylococcus aureus. Journal of Ayub Medical College, Abbottabad, 20(3), 72–74.

    PubMed  Google Scholar 

  106. Chaieb, K., Kouidhi, B., Jrah, H., et al. (2011). Antibacterial activity of thymoquinone, an active principle of Nigella sativa and its potency to prevent bacterial biofilm formation. BMC Complementary and Alternative Medicine, 11, 29–34.

    Article  PubMed  CAS  Google Scholar 

  107. Khan, M. A., Ashfaq, M. K., Zuberi, H. S., et al. (2003). The in vivo antifungal activity of the aqueous extract from Nigella sativa seeds. Phytotherapy Research, 17(2), 183–186.

    Article  PubMed  CAS  Google Scholar 

  108. Islam, S. K., Ahsan, M., Hassan, C. M., & Malek, M. A. (1989). Antifungal activities of the oils of Nigella sativa seeds. Pakistan Journal of Pharmaceutical Sciences, 2(1), 25–28.

    PubMed  CAS  Google Scholar 

  109. Ayaz, E., Yilmaz, H., Ozbek, H., et al. (2007). The effect of Nigella sativa oil against Aspiculuris tetraptera and Hymenolepis nana in naturally infected mice. Saudi Medical Journal, 28(11), 1654–1657.

    PubMed  Google Scholar 

  110. Aboul-Ela, E. I. (2002). Cytogenetic studies on Nigella sativa seeds extract and thymoquinone on mouse cells infected with schistosomiasis using karyotyping. Mutation Research, 516, 11–17.

    Article  PubMed  CAS  Google Scholar 

  111. Ilhan, A., Gurel, A., Armutcu, F., et al. (2005). Antiepileptogenic and antioxidant effects of Nigella sativa oil against pentylenetetrazol-induced kindling in mice. Neuropharmacology, 49(4), 456–464.

    Article  PubMed  CAS  Google Scholar 

  112. Perveen, T., Haider, S., Kanwal, S., & Haleem, D. J. (2009). Repeated administration of Nigella sativa decreases 5-HT turnover and produces anxiolytic effects in rats. Pakistan Journal of Pharmaceutical Sciences, 22(2), 139–144.

    PubMed  Google Scholar 

  113. Hadjzadeh, M. A., Khoei, A., Hadjzadeh, Z., & Parizady, M. (2007). Ethanolic extract of Nigella sativa L. seeds on ethylene glycol-induced kidney calculi in rats. Urology Journal, 4(2), 86–90.

    PubMed  Google Scholar 

  114. Aqel, M. B. (1993). Effect of Nigella sativa seeds on intestinal smooth muscles. International Journal of Pharmacognosy, 31, 55–60.

    Article  Google Scholar 

  115. Zaoui, A., Cherrah, Y., Mahassini, N., et al. (2002). Acute and chronic toxicity of Nigella sativa fixed oil. Phytomedicine, 9(1), 69–74.

    Article  PubMed  CAS  Google Scholar 

  116. Badary, O. A., Al-Shabanah, O. A., Nagi, M. N., et al. (1998). Acute and subchronic toxicity of thymoquinone in mice. Drug Development Research, 44, 56–61.

    Article  Google Scholar 

  117. Vahdati-Mashhadian, N., Rakhshandeh, H., & Omidi, A. (2005). An investigation on LD50 and subacute hepatic toxicity of Nigella sativa seed extracts in mice. Pharmazie, 60(7), 544–547.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ayman El-Menyar.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shabana, A., El-Menyar, A., Asim, M. et al. Cardiovascular Benefits of Black Cumin (Nigella sativa). Cardiovasc Toxicol 13, 9–21 (2013). https://doi.org/10.1007/s12012-012-9181-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12012-012-9181-z

Keywords

Navigation